These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10906743)

  • 21. [Prostate cancer screening benefit very low, even after 13 years].
    Blanker MH; Noordzij MA
    Ned Tijdschr Geneeskd; 2014; 158():A8349. PubMed ID: 25492737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Informed consent for prostate-specific antigen screening.
    Wilkinson S; Chodak G
    Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prostate cancer screening: Reasons of controversy].
    Delporte G; Villers A; Penel N
    Bull Cancer; 2018 Dec; 105(12):1111-1118. PubMed ID: 30458966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up.
    Braillon A; Dubois G
    J Natl Cancer Inst; 2012 May; 104(10):793; author reply 793-4. PubMed ID: 22491229
    [No Abstract]   [Full Text] [Related]  

  • 25. Informed consent for prostate-specific antigen-based screening.
    Brawley OW
    Urology; 2003 Jan; 61(1):10-2. PubMed ID: 12559255
    [No Abstract]   [Full Text] [Related]  

  • 26. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 27. The rationale for the ERSPC trial: will it improve the knowledge base on prostate cancer screening?
    Auvinen A; Hugosson J
    BJU Int; 2003 Dec; 92 Suppl 2():14-6. PubMed ID: 14983947
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for prostate cancer. How can patients give informed consent?
    Marshall KG
    Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A misleading paper on prostate cancer screening.
    Elwood M
    Prostate; 2004 Dec; 61(4):372; author reply 373-4. PubMed ID: 15503318
    [No Abstract]   [Full Text] [Related]  

  • 31. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Andriole GL
    Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
    Carroll PR; Whitson JM; Cooperberg MR
    J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
    [No Abstract]   [Full Text] [Related]  

  • 35. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 36. Informed consent for prostate-specific antigen screening.
    Carter HB
    Urology; 2003 Jan; 61(1):13-4. PubMed ID: 12559256
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for prostate cancer remains controversial.
    Stark JR; Mucci L; Rothman KJ; Adami HO
    BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
    [No Abstract]   [Full Text] [Related]  

  • 38. PSA-based screening for prostate cancer. Too many adverse effects.
    Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of prostate cancer. Recent evidence suggests screening may be justified in high risk younger men.
    Foulkes W
    BMJ; 1995 Apr; 310(6987):1139-40. PubMed ID: 7537993
    [No Abstract]   [Full Text] [Related]  

  • 40. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.